Skip to menu Skip to content Skip to footer

2007

Journal Article

Identification of BRCA1 missense substitutions that confer partial functional activity: potential moderate risk variants?

Lovelock, Paul K., Spurdle, Amanda B., Mok, Myth T. S., Farrugia, Daniel J., Lakhani, Sunil R., Healey, Sue, Arnold, Stephen, Buchanan, Daniel, kConFab Investigators, Couch, Fergus J., Henderson, Berik R., Goldgar, David E., Tavtigian, Sean V., Chenevix-Trench, Georgia and Brown, Melissa A (2007). Identification of BRCA1 missense substitutions that confer partial functional activity: potential moderate risk variants?. Breast Cancer Research, 9 (6: R82) R82, 1-13. doi: 10.1186/bcr1826

Identification of BRCA1 missense substitutions that confer partial functional activity: potential moderate risk variants?

2007

Journal Article

Mutation analysis of five candidate genes in familial breast cancer

Marsh, Anna, Healey, Sue, Lewis, Aaron, Spurdle, Amanda B., Kedda, Mary Anne, Khanna, Kum Kum, Mann, Graham J., Pupo, Gulietta M., Lakhani, Sunil R. and Chenevix-Trench, Georgia (2007). Mutation analysis of five candidate genes in familial breast cancer. Breast Cancer Research & Treatment, 105 (3), 377-389. doi: 10.1007/s10549-006-9461-z

Mutation analysis of five candidate genes in familial breast cancer

2007

Journal Article

Genome-wide association study identifies novel breast cancer susceptibility loci

Easton, Douglas F., Pooley, Karen A., Dunning, Alison M., Pharoah, Paul D. P., Thompson, Deborah, Ballinger, Dennis G., Struewing, Jeffery P., Morrison, Jonathan, Field, Helen, Luben, Robert, Wareham, Nicholas, Ahmed, Shahana, Healey, Catherine S., Bowman, Richard, SEARCH collaborators, Meyer, Kerstin B., Haiman, Christopher A., Kolonel, Laurence K., Henderson, Brian E., Marchand, Loic Le, Brennan, Paul, Sangrajrang, Suleeporn, Gaborieau, Valerie, Odefrey, Fabrice, Shen, Chen-Yang, Wu, Pei-Ei, Wang, Hui-Chun, Eccles Diana, Evans, D. Gareth ... Ward, Robyn (2007). Genome-wide association study identifies novel breast cancer susceptibility loci. Nature, 447 (7148), 1087-1093. doi: 10.1038/nature05887

Genome-wide association study identifies novel breast cancer susceptibility loci

2007

Journal Article

Demystifying basal-like breast carcinomas

Da Silva, L., Clarke, C. and Lakhani, S.R. (2007). Demystifying basal-like breast carcinomas. Journal of Clinical Pathology, 60 (12), 1328-1332. doi: 10.1136/jcp.2006.041731

Demystifying basal-like breast carcinomas

2007

Journal Article

Comparative molecular pathology of adenoid cystic carcinoma from different sites: A microarray-based CGH analysi

Fulford, L. G., Reis, J. S., Mackay, A., Fenwick, K., Iravani, M., Ashworth, A., Nicholson, A. G., Schmitt, F. C., Simpson, H. W. and Lakhani, S. R. (2007). Comparative molecular pathology of adenoid cystic carcinoma from different sites: A microarray-based CGH analysi. Laboratory Investigation, 87 (Supplement 1s), 305A-306A. doi: 10.1038/sj.labinvest.3700582

Comparative molecular pathology of adenoid cystic carcinoma from different sites: A microarray-based CGH analysi

2007

Journal Article

Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival

Fulford, Laura G., Reis-Filho, Jorge S., Ryder, Ken, Jones, Chris, Gillett, Cheryl E., Hanby, Andrew, Easton, Douglas and Lakhani, Sunil R. (2007). Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival. Breast Cancer Research, 9 (1) R4, 1-11. doi: 10.1186/bcr1636

Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival

2007

Conference Publication

Evidence of evolution and intrinsic molecular relationship in a spectrum of morphological variants of invasive lobular carcinoma with variable E-cadherin status

Da Silva, L., Parry, S., Keith, P., Lakhani, S. R. and Simpson, P. (2007). Evidence of evolution and intrinsic molecular relationship in a spectrum of morphological variants of invasive lobular carcinoma with variable E-cadherin status. United States and Canadian Academy of Pathology 2007 Annual Meeting, San Diego, California, 24-30 March, 2007. Baltimore, MD: Nature Publishing.

Evidence of evolution and intrinsic molecular relationship in a spectrum of morphological variants of invasive lobular carcinoma with variable E-cadherin status

2007

Conference Publication

Targeted disruption of Brca1 in restricted compartments of the mouse mammary epithelia

Brewster, Brooke, Brooks, Kelly, Brown, Melissa Anne, Clarke, C., Fleming, J. S., French, J. D., Hetherington, Rehan, Lakhani, Sunil, Raghavendra, Ashwini, Rothnagel, Joseph, Smart, Chanel and Wainwright, Brandon (2007). Targeted disruption of Brca1 in restricted compartments of the mouse mammary epithelia. Gordon Research Conference: Mammary Gland Biology, Newport, RI, 10-15 June 2007.

Targeted disruption of Brca1 in restricted compartments of the mouse mammary epithelia

2007

Conference Publication

Targeted disruption of Brca1 in restricted compartments of the mouse mammary epithelia

Smart, C. E., Clarke, C., Brooks, K. M., Raghavendra, A., Brewster, B. L., French, J. D., Hetherington, R., Fleming, J. S., Rothnagel, J. A., Wainwright, B., Lakhani, S. R. and Brown, M. A. (2007). Targeted disruption of Brca1 in restricted compartments of the mouse mammary epithelia. Australian Breast Cancer Conference, Melbourne, Australia, 2007.

Targeted disruption of Brca1 in restricted compartments of the mouse mammary epithelia

2007

Journal Article

Comparative molecular pathology of adenoid cystic carcinoma from different sites: A microarray-based CGH analysis

Fulford, L. G., Reis, J. S., Mackay, A., Feinwick, K., Iravani, M., Ashworth, A., Nicholson, A. G., Schmitt, F. C., Simpson, R. H. W. and Lakhani, Sunil R. (2007). Comparative molecular pathology of adenoid cystic carcinoma from different sites: A microarray-based CGH analysis. Modern Pathology, 20 (Supplement 2s), 305A-306A. doi: 10.1038/sj.modpathol.3800815

Comparative molecular pathology of adenoid cystic carcinoma from different sites: A microarray-based CGH analysis

2007

Conference Publication

Targeted disruption of Brca1 in restricted compartments of the mouse mammary epithelia

Brewster, Brooke, Brooke, Kelly, Brown, Melissa Anne, Clarke, C., Fleming, J. S., French, J. D., Hetherington, Rehan, Lakhani, Sunil, Raghavendra, Ashwini, Rothnagel, Joseph, Smart, Chanel and Wainwright, Brandon (2007). Targeted disruption of Brca1 in restricted compartments of the mouse mammary epithelia. kConFab Familial Breast Cancer Conference, Couran Cove, Queensland, 21-24 August 2007.

Targeted disruption of Brca1 in restricted compartments of the mouse mammary epithelia

2007

Book Chapter

Pathology of ovarian tumors in mutation carriers

Penault-Llorca, Frédérique and Lakhani, Sunil R. (2007). Pathology of ovarian tumors in mutation carriers. Hereditary breast cancer. (pp. 333-344) edited by Claudine Isaacs and Timothy R. Rebbeck. Boca Raton, FL, United States: CRC Press. doi: 10.3109/9781420020366-23

Pathology of ovarian tumors in mutation carriers

2007

Journal Article

In situ carcinoma - can we predict which patient will come back with a recurrence?

Simpson, P.T., Da Silva, L. M and Lakhani, S.R. (2007). In situ carcinoma - can we predict which patient will come back with a recurrence?. Cancer Cell, 12 (5), 409-411. doi: 10.1016/j.ccr.2007.10.026

In situ carcinoma - can we predict which patient will come back with a recurrence?

2006

Journal Article

FGFR1 emerges as a potential therapeutic target for lobular breast carcinomas

Reis-Filho, Jorge Sergio, Simpson, Pete T., Turner, Nicholas C., Lambros, Maryou Ballo, Jones, Chris, Mackay, Alan, Grigoriadis, Anita, Sarrio, David, Savage, Kay, Dexter, Tim, Iravani, Marjan, Fenwick, Kerry, Weber, Barbara, Hardisson, David, Schmitt, Fernando Carlos, Palacios, Jose, Lakhani, Sunil R. and Ashworth, Alan (2006). FGFR1 emerges as a potential therapeutic target for lobular breast carcinomas. Clinical Cancer Research, 12 (22), 6652-6662. doi: 10.1158/1078-0432.CCR-06-1164

FGFR1 emerges as a potential therapeutic target for lobular breast carcinomas

2006

Journal Article

Genetic and Histopathologic Evaluation of BRCA1 and BRCA2 DNA Sequence Variance of Unknown Clinical Significance

Chenevix-Trench, Georgia, Healey, Sue, Lakhani, Sunil, Waring, Paul, Cummings, Margaret, Brinkworth, Ross, Deffenbaugh, Amie M., Burbidge, Lynn Anne, Pruss, Dmitry, Judkins, Thad, Scholl, Tom, Bekessy, Anna, Marsh, Anna, Lovelock, Paul, Wong, Ming, Tesoriero, Andrea, Renard, Helene, Southey, Melissa, Hopper, John L., Yannoukakos, Koulis, Brown, Melissa, kConFab Investigators, Easton, Douglas, Tavtigian, Sean V., Goldgar, David and Spurdle, Amanda B. (2006). Genetic and Histopathologic Evaluation of BRCA1 and BRCA2 DNA Sequence Variance of Unknown Clinical Significance. Cancer Research, 66 (4), 2019-2027. doi: 10.1158/0008-5472.CAN-05-3546

Genetic and Histopathologic Evaluation of BRCA1 and BRCA2 DNA Sequence Variance of Unknown Clinical Significance

2006

Book Chapter

Molecular investigation of breast disease

Jones, Chris and Lakhani , Sunil R. (2006). Molecular investigation of breast disease. Early breast cancer: From screening to multidisciplinary management. (pp. 319-327) edited by G. Querci della Rovere, R. Warren and John R. Benson. London, U.K. ; New York, U.S.A.: Informa Healthcare.

Molecular investigation of breast disease

2006

Journal Article

Pathological complete response and residual DCIS following neoadjuvant chemotherapy for breast carcinoma

Jones, R. L., Lakhani, S. R., Ring, A. E., Ashley, S., Walsh, G. and Smith, I. E. (2006). Pathological complete response and residual DCIS following neoadjuvant chemotherapy for breast carcinoma. British Journal of Cancer, 94 (3), 358-362. doi: 10.1038/sj.bjc.6602950

Pathological complete response and residual DCIS following neoadjuvant chemotherapy for breast carcinoma

2006

Journal Article

Mapping loss of heterozygosity in normal human breast cells from BRCA1/2 carriers

Clarke, C. L., Sandle, J., Jones, A. A., Sofronis, A., Patani, N. R. and Lakhani, S. R. (2006). Mapping loss of heterozygosity in normal human breast cells from BRCA1/2 carriers. British Journal of Cancer, 95 (4), 515-519. doi: 10.1038/sj.bjc.6603298

Mapping loss of heterozygosity in normal human breast cells from BRCA1/2 carriers

2006

Journal Article

EGFR amplification and lack of activating mutations in metaplastic breast carcinomas

Reis-Filho, J. S., Pinheiro, C., Lambros, M. B. K., Milanezi, F., Carvalho, S., Savage, K., Simpson, P. T., Jones, C., Swift, S., Mackay, A., Reis, R. M., Hornick, J. L., Pereira, E. M., Baltazar, F., Fletcher, C. D. M., Ashworth, A., Lakhani, S. R. and Schmitt, F. C. (2006). EGFR amplification and lack of activating mutations in metaplastic breast carcinomas. Journal of Pathology, 209 (4), 445-453. doi: 10.1002/path.2004

EGFR amplification and lack of activating mutations in metaplastic breast carcinomas

2006

Journal Article

Cost-effectiveness of screening with contrast enhanced magnetic resonance imaging vs X-ray mammography of women at a high familial risk of breast cancer

Griebsch, I., Brown, J., Boggis, C., Dixon, A., Dixon, M., Easton, D., Eeles, R., Evans, D. G., Gilbert, F. J., Hawnaur, J., Kessar, P., Lakhani, S. R., Moss, S. M., Nerurkar, A. and Padhani, A. R. (2006). Cost-effectiveness of screening with contrast enhanced magnetic resonance imaging vs X-ray mammography of women at a high familial risk of breast cancer. British Journal of Cancer, 95 (7), 801-810. doi: 10.1038/sj.bjc.6603356

Cost-effectiveness of screening with contrast enhanced magnetic resonance imaging vs X-ray mammography of women at a high familial risk of breast cancer